# Formfactor Inc: Form 10-Q for the period ended Sep 28, 2013

- Company: [Formfactor Inc](/companies/form.md) (CIK 1039399)
- Form: 10-Q
- Filed: 2013-11-01
- Accepted by EDGAR: Nov 1, 2013, 16:31 ET
- Period: 2013-09-28
- Accession: 0001039399-13-000015
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1039399/000103939913000015/form-20130928x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1039399/000103939913000015/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-06-30 to 2013-09-28 | $67.6m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2012-12-30 to 2013-09-28 | $183.0m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2013-06-30 to 2013-09-28 | $55.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2012-12-30 to 2013-09-28 | $145.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2013-06-30 to 2013-09-28 | $12.5m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2012-12-30 to 2013-09-28 | $38.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2013-06-30 to 2013-09-28 | $10.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2012-12-30 to 2013-09-28 | $32.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2013-06-30 to 2013-09-28 | $13.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2012-12-30 to 2013-09-28 | $41.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-06-30 to 2013-09-28 | −$10.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-12-30 to 2013-09-28 | −$39.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-06-30 to 2013-09-28 | −$147.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2012-12-30 to 2013-09-28 | −$152.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-06-30 to 2013-09-28 | −$10.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2012-12-30 to 2013-09-28 | −$38.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 9 months, 2012-12-30 to 2013-09-28 | −$0.72 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2012-12-30 to 2013-09-28 | −$2.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2012-12-30 to 2013-09-28 | $7.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2012-12-30 to 2013-09-28 | $5.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-09-28 | $59.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-09-28 | $237.9m | us-gaap:AssetsCurrent |
| Total assets | at 2013-09-28 | $372.9m | us-gaap:Assets |
| Current liabilities | at 2013-09-28 | $51.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-09-28 | $62.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2013-09-28 | $310.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 44,536 characters.

### Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, which are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements include statements concerning, among other things, our business strategy, including anticipated trends and developments in and management plans for our business and the markets in which we operate, such as projected market demands, projected technologies and products and industry acceptance and adoption of same, research and development programs, and sales and marketing initiatives, and financial results and operating results such as revenues, gross margins, operating expenses, projected costs and capital expenditures, and competition. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “could,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “intend” and “continue,” the negative or plural of these words and other comparable terminology.

The forward-looking statements are only predictions based on our current expectations and our projections about future events. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to us as of the filing date of this Quarterly Report on Form 10-Q. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these statements for any reason. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include the matters discussed in the section titled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 29, 2012 and elsewhere in this Quarterly Report on Form 10-Q. You should carefully consider the numerous risks and uncertainties described under these sections.

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the accompanying notes contained in this Quarterly Report on Form 10-Q. Unless expressly stated or the context otherwise requires, the terms “we,” “our,” “us” and “FormFactor” refer to FormFactor, Inc. and its subsidiaries.

### Overview

We design, develop, manufacture, sell and support precision, high performance advanced semiconductor wafer probe card products and solutions. We are the largest probe card manufacturer, and semiconductor manufacturers use our wafer probe cards to perform wafer sort and test on semiconductor die, or chips, prior to wafer singulation. We work closely with our customers on product design, as each wafer probe card is a custom product that is specific to the chip and wafer designs of the customer. During wafer sort and test, a wafer probe card is mounted in a prober and electrically connected to a semiconductor tester. The wafer probe card is used as an interface to connect electrically with and test individual chips on a wafer. Our wafer probe cards are used by our customers in the front end of the semiconductor manufacturing process, as are our image sensor, parametric or in-line probe cards. We operate in a single industry segment and have derived substantially all of our revenues from the sale of wafer probe cards incorporating our proprietary technology, including our MicroSpring® interconnect technology and our ATRE™ test technology.

During the three and nine months ended September 28, 2013, total revenue increased by 64% and 40%, respectively, compared to the corresponding period in fiscal 2012. During the three and nine months ended September 28, 2013, DRAM sales were up 11% and down 10%, respectively, compared to the corresponding period in fiscal 2012. SoC sales for the three and nine months ended September 28, 2013 increased 360% and 293%, respectively, compared to the corresponding periods in fiscal 2012, primarily attributable to the MicroProbe Acquisition, as defined below. Flash memory sales for the three and nine months ended September 28, 2013, declined 15% and 14% versus the same period of fiscal 2012 due to lower market demand.

We incurred a net loss of $38.9 million in the first nine months of fiscal 2013 as compared to a net loss of $36.1 million in the first nine months of fiscal 2012. The increase in net loss is primarily attributable to an increase in restructuring costs and higher intangible amortization costs and amortization of inventory step-up and backlog related to the MicroProbe Acquisition. The amortization of the inventory and backlog step-up is complete. Amortization expense related to the MicroProbe Acquisition totaled $12.9 million for the first nine months of fiscal 2013, which includes amortization of the fixed asset fair value step-up. We also incurred acquisition and integration costs totaling $1.3 million that were not incurred in the corresponding period of 2012. Excluding these non-recurring and MicroProbe Acquisition related costs, our gross margins and operating margins improved as a result of our ongoing initiatives to reduce manufacturing overhead costs, lower production material costs and reduce operating expenses.

Our cash, cash equivalents and marketable securities and restricted cash totaled $157 million as of September 28, 2013, as compared to $166 million at December 29, 2012. The decrease in our cash, cash equivalents and marketable securities balances was primarily due to the use of cash for operating activities in the first fiscal quarter of 2013. In the second and third fiscal quarters of 2013 we generated approximately $1 million and approximately $1.8 million of cash, respectively. We believe that we will be able to satisfy our working capital requirements for the next twelve months with the liquidity provided by our existing cash, cash equivalents and marketable securities. If we are unsuccessful in increasing our revenues, improving our operating efficiency, reducing our cash outlays or increasing our available cash through financing, our cash, cash equivalents and marketable securities will decline in future fiscal quarters.

In the latter part of the third fiscal quarter of 2013, we began to experience a significant drop in demand caused primarily by execution challenges that resulted in withheld orders at one customer and a fire at SK Hynix’s Wuxi, China facility that impacted probe card orders. This decline in demand resulted in lower than forecasted manufacturing utilization and coupled with lower margins on a specific high-volume DRAM design, increased warranty and service expenses caused by the execution challenges at a specific customer and increased excess inventory charges, negatively affected our gross margin for the third quarter. We expect the decline in demand will also adversely affect our revenue and profitability in the fourth fiscal quarter of 2013.

We believe the following information is important to understanding our business, our financial statements and the remainder of this discussion and analysis of our financial condition and results of operations:

*MicroProbe Acquisition.* On October 16, 2012, pursuant to an Agreement and Plan of Merger and Reorganization dated as of August 31, 2012, a wholly-owned subsidiary of FormFactor merged with and into Astria Semiconductor Holding, Inc., including its subsidiary MicroProbe, Inc. (together “MicroProbe”), with Astria continuing as the surviving corporation and as a wholly-owned subsidiary of FormFactor (the "MicroProbe Acquisition").

MicroProbe is a semiconductor equipment company that designs, develops, manufactures, sells and services high performance, custom designed advanced SoC wafer probe cards and analytical test equipment used in the semiconductor industry. MicroProbe is a global company with operations in the U.S. and Asia, including China, South Korea, Singapore and Taiwan. The acquisition of MicroProbe enables us to leverage the combination of two advanced wafer probe card manufacturers and expand our SoC product portfolio to meaningfully diversify our business.

*Revenues.* We derive substantially all of our revenues from product sales of wafer probe cards. Revenues from our customers are subject to fluctuations due to factors including, but not limited to, design cycles, technology adoption rates, competitive pressure to reduce prices, seasonality, cyclicality of the different end markets into which our customers' products are sold, market conditions in the semiconductor industry and macroeconomic issues. Historically, increases in revenues have resulted from increased demand for our existing products, the introduction of new, more complex products and the penetration of new markets. We expect that revenues from the sale of wafer probe cards will continue to account for substantially all of our revenues for the foreseeable future.

*Cost of Revenues.* Cost of revenues consists primarily of manufacturing materials, payroll, shipping and handling costs and manufacturing-related overhead. Our manufacturing operations rely upon a limited number of suppliers to provide key components and materials for our products, some of which are a sole source. We order materials and supplies based on backlog and forecasted customer orders. Tooling and setup costs related to changing manufacturing lots at our suppliers are also included in the cost of revenues. We expense all warranty costs and inventory write-down as cost of revenues.

We design, manufacture and sell custom advanced wafer probe cards into the semiconductor test market, which is subject to significant variability and demand fluctuations. Our wafer probe cards are complex products that are custom to a specific chip design of a customer and must be delivered on relatively short lead-times as compared to our overall manufacturing process. Our advanced wafer probe cards are manufactured in low volumes. It is not uncommon for us to acquire production materials and start certain production activities based on estimated production yields and forecasted demand prior to, and/or in excess of, actual demand for our wafer probe cards. We record an adjustment to our inventory valuation for estimated obsolete and non-sellable inventories based on historical usage and assumptions about future demand, changes to manufacturing processes and overall market conditions.

*Research and Development.* Research and development expenses include expenses related to product development, design, engineering and material costs. All research and development costs are expensed as incurred. We plan to continue to invest in research and development activities to improve and enhance existing product technologies, to develop new products and product architectures, and to develop new technologies for current and new products and for new applications.

*Selling, General and Administrative.* Selling, general and administrative expenses include expenses related to sales, marketing, and administrative personnel, provision for doubtful accounts, internal and outside sales representatives' commissions, market research and consulting, and other sales, marketing and administrative activities. These expenses also include costs for protecting and enforcing our intellectual property rights and regulatory compliance costs.

*Restructuring Charges.* Restructuring charges include costs related to employee termination benefits, costs of long-lived assets abandoned or impaired, as well as contract termination costs.

*Impairment of Long-Lived Assets.* Asset impairment charges include charges associated with the write down of assets that have no future expected benefit or assets for which circumstances indicate that the carrying amount of these assets may not be recoverable, as well as adjustments to the carrying amount of our assets held for sale.

### Results of Operations

The following table sets forth our operating results as a percentage of revenues for the periods indicated:

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of revenues | 81.5 | 80.2 | 79.2 | 78.2 |
| Gross profit | 18.5 | 19.8 | 20.8 | 21.8 |
| Operating expenses: |  |  |  |  |
| Research and development | 15.2 | 20.8 | 17.6 | 23.2 |
| Selling, general and administrative | 19.2 | 28.1 | 22.4 | 26.2 |
| Restructuring charges, net | 0.2 | 6.0 | 2.3 | 2.0 |
| Loss on sale of subsidiary | — | — | 0.2 | — |
| Impairment of long-lived assets | — | 0.3 | 0.1 | 0.3 |
| Total operating expenses | 34.6 | 55.2 | 42.6 | 51.7 |
| Operating loss | (16.1) | (35.4) | (21.8) | (29.9) |
| Interest income, net | 0.1 | 0.4 | 0.2 | 0.4 |
| Other income (expense), net | (0.1) | 0.4 | 0.3 | 0.9 |
| Loss before income taxes | (16.1) | (34.6) | (21.3) | (28.6) |
| Provision for (benefit from) income taxes | (0.2) | 0.4 | (0.1) | (1.0) |
| Net loss | (15.9)% | (35.0)% | (21.2)% | (27.6)% |

### Three and nine months ended September 28, 2013 and September 29, 2012:

### Revenues

#### Revenues by Market

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | % Change | Nine Months Ended September 28, 2013 | September 29, 2012 | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| DRAM | $28,852 | $25,993 | 11.0% | $77,501 | $85,995 | (9.9)% |
| Flash | 7,082 | 8,374 | (15.4) | 19,840 | 23,092 | (14.1) |
| SoC | 31,700 | 6,895 | 359.8 | 85,646 | 21,794 | 293.0 |
| Total revenues | $67,634 | $41,262 | 63.9% | $182,987 | $130,881 | 39.8% |

26

Revenues for the three and nine months ended September 28, 2013 increased 64%, or $26.4 million, and 40%, or $52.1 million, respectively, compared to the corresponding periods in the prior year. For the three months ended September 28, 2013, our revenue increased approximately 11% in our DRAM products, decreased approximately 15% in our Flash memory products, and increased 360% in our SoC products as compared to the corresponding period in the prior year. These fluctuations in revenue were primarily driven by unit volume in the DRAM and Flash memory product markets and our MicroProbe acquisition in the SoC product market. Smart phone and tablet DRAM demand increased in the three months ended September 28, 2013 compared to the corresponding period in 2012, offset partially by a drop in PC-related DRAM demand.

The reduction in Flash memory revenue was primarily in the NOR area resulting from soft demand in the nine months ended September 28, 2013 for the sector.

Overall, our SoC revenues increased by $24.8 million and $63.9 million in the first three and nine months of fiscal 2013, respectively, compared to the same period in 2012, primarily due to the MicroProbe Acquisition.

#### Revenues by Geographic Region

The following table sets forth our revenues by geographic region for the periods indicated:

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | % of Revenue | September 29, 2012 | % of Revenue | Nine Months Ended September 28, 2013 | % of Revenue | September 29, 2012 | % of Revenue |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| North America | $17,252 | 25.5% | $4,388 | 10.6% | $46,868 | 25.6% | $13,050 | 10.0% |
| Taiwan | 22,953 | 33.9 | 6,979 | 16.9 | 54,128 | 29.6 | 28,059 | 21.4 |
| South Korea | 12,562 | 18.6 | 12,042 | 29.2 | 37,769 | 20.6 | 47,986 | 36.7 |
| Asia-Pacific (1) | 4,470 | 6.6 | 8,080 | 19.6 | 16,732 | 9.2 | 17,735 | 13.6 |
| Japan | 6,072 | 9.0 | 8,060 | 19.5 | 14,499 | 7.9 | 19,434 | 14.8 |
| Europe | 4,325 | 6.4 | 1,713 | 4.2 | 12,991 | 7.1 | 4,617 | 3.5 |
| Total revenues | $67,634 | 100.0% | $41,262 | 100.0% | $182,987 | 100.0% | $130,881 | 100.0% |

(1) Asia-Pacific includes all countries in the region except Taiwan, Japan and South Korea, which are disclosed separately.

Geographic revenue information is based on the location to which we ship the customer product. For example, if a certain South Korean customer purchases through their North American subsidiary and requests the products to be shipped to an address in Asia-Pacific, this sale will be reflected in the revenues for Asia-Pacific rather than North America.

The increase in North America, Asia-Pacific and Europe sales for the three and nine months ended September 28, 2013, when compared to the same periods in 2012, is driven by SOC product shipments primarily from our MicroProbe Acquisition. MicroProbe's sales were not included in our consolidated revenues for the three and nine months ended September 29, 2012. The increase in Taiwan sales for the three and nine months ended September 28, 2013, when compared to same periods in 2012, is driven by a combination of SOC product shipments from our MicroProbe Acquisition and an increase in mobile phone and tablet-based DRAM and Flash demand. The increase in South Korea revenues for the three months ended September 2013 when compared to the same period in 2012 was primarily due to mobile processor-based SOC product shipments from our MicroProbe Acquisition. The decrease in South Korea revenues for the nine months ended September 2013 was due to reduced PC-related DRAM memory demand based on overall end-market demand and lower demand for our higher parallelism Flash product at a single customer. The decrease in Japan sales was driven by lower demand for our SmartMatrix product at a major mobile DRAM producer.

The following customers accounted for more than 10% of our revenues for the periods indicated:

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Micron | 19.0% |  | 10.2% |  |
| Intel | 15.5% | \* | 15.8% | \* |
| SK Hynix | 12.4% | 30.1% | 17.0% | 34.4% |
| Samsung | \* | 15.6% | \* | 13.1% |
| Elpida | \* | 14.7% | \* | \* |
|  | 46.9% | 60.4% | 43.0% | 47.5% |

\* Less than 10% of revenues.

### Gross Profit

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Gross profit | $12,546 | $8,152 | $38,026 | $28,475 |
| % of revenues | 18.5% | 19.8% | 20.8% | 21.8% |

Gross profit fluctuates with revenue, product mix, selling prices, factory loading, and material costs. For the three and nine months ended September 28, 2013, the amount of gross profit increased compared to the same period in the prior year, primarily due to gross profit from the MicroProbe Acquisition, lower material costs, lower labor expenses and reduced overhead charges as a result of our cost reduction initiatives. This was partially offset by higher intangible amortization expenses associated with the MicroProbe Acquisition.

For the three and nine months ended September 28, 2013, the primary driver for the increase in gross profit was the MicroProbe Acquisition. MicroProbe's financial results are not included in gross profit for the three or nine months ended September 29, 2012. Our gross profit improvement was also driven by our cost reduction activities including the cessation of our Japan assembly and test activities in the fourth quarter of 2012, and other personnel restructuring actions and material cost reduction initiatives. Gross profit improvement was offset by an increase in net inventory provision charges of $1.1 million for the three months ended September 28, 2013 and $3.5 million for the first-nine months of fiscal 2013. For the three and nine months ended September 28, 2013, the value of previously reserved materials that were used in manufacturing and shipped was $0.8 million and $1.6 million, respectively.

Gross profit included stock-based compensation of $0.5 million and $1.7 million for the three and nine months ended September 28, 2013, respectively, compared to $0.6 million and $1.8 million for the three and nine months ended September 29, 2012, respectively.

Following the MicroProbe Acquisition, gross profit also included $3.2 million and $10.6 million of amortization of intangible assets in the three and nine months ended September 28, 2013, respectively.

In the future, our gross profits may be adversely impacted by lower levels of product revenues, even though we have taken significant steps to reduce our operating cost structure. Our gross profits may also be adversely affected if we are required to record additional inventory provision charges and inventory write-downs when estimated average selling prices of products held in finished goods and work in process inventories are below the manufacturing cost of those products.

### Research and Development

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| R&D | $10,301 | $8,573 | $32,145 | $30,355 |
| % of revenues | 15.2% | 20.8% | 17.6% | 23.2% |

Research and development expenses for the three and nine months ended September 28, 2013 increased by $1.7 million and $1.8 million, respectively, compared to the same periods in the prior year. While research and development expenses increased due to the MicroProbe Acquisition, this increase was partially offset by a decrease in other expenses as a result of our cost reduction efforts. As a percent of revenues, research and development expenses decreased 5.6% during the three months ended September 28, 2013 from the comparable period of the prior year due to our cost reduction efforts.

In the three and nine months ended September 28, 2013, costs related to our research and development activities increased from fiscal 2012 due to a net increase in headcount and personnel related costs of $0.9 million and $2 million, respectively, primarily due to the Microprobe Acquisition. This increase was partially offset by reduced headcount from ongoing restructuring activities. In the three months ended September 28, 2013, project and material costs also increased $0.7 million compared to the same period in the prior year.

Stock-based compensation expenses included in research and development expenses were $0.8 million and $2.7 million for the three and nine months ended September 28, 2013, respectively, compared to $1.0 million and $3.3 million for the three and nine months ended September 29, 2012 respectively.

### Selling, General and Administrative

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $12,952 | $11,594 | $41,057 | $34,273 |
| % of revenues | 19.2% | 28.1% | 22.4% | 26.2% |

Selling, general and administrative expenses for the three and nine months ended September 28, 2013 increased $1.4 million and $6.8 million, respectively, compared to the same periods in the prior year. Selling, general and administrative expenses increased primarily due to the MicroProbe Acquisition. As a percent of revenues, selling, general and administrative expenses decreased approximately 9.0% during the three months ended September 28, 2013 from the comparable period of the prior year due to our cost reduction efforts.

For the three and nine months ended September 28, 2013, salary and payroll related costs for selling, general and administrative functions increased by $1.2 million and $3.6 million, respectively, as compared to the same periods in the prior year primarily due to the MicroProbe Acquisition. Additionally, amortization costs arising from intangible assets valued from the MicroProbe Acquisition increased by $2.3 million for the nine months ended September 28, 2013 as compared to the same period last year.

Stock-based compensation expenses included within selling, general and administrative expense were $1.6 million and $4.8 million, respectively for the three and nine months ended September 28, 2013 compared to $1.4 million and $4.4 million, respectively for the same periods in the prior year. Stock-based compensation expense increased due to grants to MicroProbe employees.

### Restructuring Charges, net

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges, net | $143 | $2,481 | $4,215 | $2,584 |
| % of revenues | 0.2% | 6.0% | 2.3% | 2.0% |

For the three and nine months ended September 28, 2013, restructuring charges decreased by $2.3 million and increased by $1.6 million, respectively from the comparable periods of the prior year. Our restructuring activities are discussed below.

#### 2013 Restructuring Activities

In the first-fiscal quarter of 2013, we implemented a restructuring plan (the "Q1 2013 Restructuring Plan") which resulted in the reduction of our global workforce by 31 employees across the organization. In addition we reduced our temporary workforce by approximately 20 positions. We also suspended development activities and engineering efforts for our next generation DRAM Matrix platform and terminated development activities for a certain SoC product platform. We recorded $4.0 million of restructuring charges during the first fiscal quarter of 2013, which was comprised of $1.3 million in severance and related benefits and $2.7 million in impairment charges for certain equipment that would no longer be utilized. As a result of the Q1 2013 Restructuring Plan, we expect to realize quarterly savings, excluding stock-based compensation, in the range of $2.0 million to $2.5 million in subsequent quarters.

#### 2012 Restructuring Activities

In the third fiscal quarter of 2012, we implemented a restructuring plan (the "Q3 2012 Restructuring Plan") which resulted in the reduction of our global workforce by 44 employees across the organization. In conjunction with this action, we also initiated a plan to cease our manufacturing operations in Japan. We recorded $1.8 million in charges for severance and related benefits, $0.2 million in charges for contract termination and other costs and $0.4 million in impairment charges for certain equipment and leasehold improvements that would no longer be utilized. The activities comprising this reduction in workforce were completed by the end of the fourth quarter of fiscal 2012.

The liabilities we have accrued represent our best estimate of the obligations we expect to incur and could be subject to adjustment as market conditions change. The remaining cash payments associated with our various reductions in workforce are expected to be paid by the end of the fourth quarter of fiscal 2013.

### Loss on Sale of Subsidiary

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Loss on sale of subsidiary | $— | $— | $300 | $— |
| % of revenues | —% | —% | 0.2% | —% |

30

On June 29, 2013, we sold TMMC, a wholly owned subsidiary of MicroProbe based in Carson City, Nevada. TMMC manufactures manual, analytical probe stations and accessories. TMMC's assets were sold to its management team for a purchase consideration of $1.0 million. FormFactor received $180 thousand in cash upon the sale and an $820 thousand note to be repaid over 7 years at a 5% interest rate. The fair value of the note was discounted to $470 thousand as of June 29, 2013. We included goodwill of $177 thousand and a trademark intangible asset, net of accumulated amortization, of $104 thousand in the loss on disposal of a subsidiary. We recorded a net loss on the sale of TMMC's assets of $300 thousand.

### Impairment of Long-lived Assets

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Impairment of long-lived assets | $15 | $143 | $194 | $372 |
| % of revenues | —% | 0.3% | 0.1% | 0.3% |

During the three and nine months ended September 28, 2013, we recorded an impairment charge of $15 thousand and $194 thousand, respectively, related to certain manufacturing assets which will no longer be utilized.

During the nine months ended September 29, 2012, we recorded an impairment charge of $0.4 million related to certain assets which were previously held for sale that we determined to no longer be salable and would not be used for internal purposes.

Management believes it is reasonably possible that additional impairment charges that would further reduce the carrying amounts of our property, plant and equipment and intangible assets may arise in fiscal 2013 if we are unable to achieve cash flows anticipated by our forecasted financial plan.

### Interest Income, Net and Other Income (Expense), Net

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Interest income, net | $95 | $163 | $298 | $557 |
| % of revenue | 0.1% | 0.4% | 0.2% | 0.4% |
| Other income (expense), net | $(91) | $171 | $541 | $1,127 |
| % of revenues | (0.1)% | 0.4% | 0.3% | 0.9% |

Interest income is primarily earned on our cash, cash equivalents and marketable securities. The decrease in interest income for the three and nine months ended September 28, 2013 as compared with the same periods of the prior year was primarily the result of lower average balances which was partially offset by interest income from our note receivable from TMMC-refer to Note 7 to the Notes to Condensed Consolidated Financial Statements for further details. Cash, cash equivalents, restricted cash and marketable securities were $156.8 million at September 28, 2013 compared to $166.1 million at December 29, 2012, and $276.5 million at September 29, 2012. The weighted-average yield on our cash, cash equivalents and marketable securities for the three months ended September 28, 2013 and September 29, 2012 was 0.21% and 0.25%, respectively, and the weighted average yield for the nine months ended September 28, 2013 and September 29, 2012 was 0.27% and 0.29%, respectively.

Other income (expense), net is comprised primarily of foreign currency impact and various other gains and losses. The decrease in other income, net for the three and nine months ended September 28, 2013 compared to September 29, 2012, was due primarily to foreign currency exchange losses as well as payments received from an intellectual property settlement during fiscal 2012.

### Provision for (Benefit From) Income Taxes

*(In thousands, except percentages)*

|  | Three Months Ended September 28, 2013 | September 29, 2012 | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Provision for (benefit from) income taxes | $(147) | $173 | $(152) | $(1,276) |
| Effective tax rate | 1.4% | (1.2)% | 0.39% | 3.4% |

We recorded an income tax benefit of $0.1 million and $0.2 million for the three and nine months ended September 28, 2013, respectively, as compared to an income tax provision of $0.2 million and an income tax benefit of $1.3 million for the three and nine months ended September 29, 2012, respectively. Our income tax provisions reflect the tax provision on our non-U.S. operations in foreign jurisdictions and the tax benefit from the lapsing of the statute of limitations in US and foreign jurisdictions and reinstatement of the Federal R&D tax credit which was retroactively applied to 2012.

We recognized interest and penalties related to uncertain tax positions as part of the income tax provision. For the three and nine months ended September 28, 2013, we recognized an interest benefit, net of penalties, of approximately $0.1 million and $0.2 million, respectively. For the three and nine months ended September 29, 2012, we recognized an interest benefit, net of penalties, of approximately $4 thousand and $0.3 million, respectively. As of September 28, 2013 and September 29, 2012, we have accrued total interest and penalties of $0.2 million and $0.3 million related to the uncertain tax positions, respectively.

We anticipate that we will continue to record a valuation allowance against our U.S. and certain non U.S. deferred tax assets. We expect our future tax provisions, during the time such valuation allowances are recorded, will consist primarily of the tax provision of our profitable non-U.S. jurisdictions.

Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to Federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates, deductibility of certain costs and expenses by jurisdiction.

### Liquidity and Capital Resources

***Capital Resources:*** Our working capital was $186.0 million at September 28, 2013 and $194.1 million at December 29, 2012. The decrease in working capital in the nine months ended September 28, 2013 was primarily due to the use of cash, cash equivalents and marketable securities to fund operations and fixed asset purchases.

Cash and cash equivalents consist of deposits held at banks, money market funds, U.S. government securities and commercial paper that at the time of purchase had maturities of 90 days or less. Marketable securities consist of U.S. government and agency securities and commercial paper. We typically invest in highly-rated securities with low probabilities of default. Our investment policy requires investments to be rated single-A or better, and limits the types of acceptable investments, issuer concentration and duration of the investment.

Our cash, cash equivalents and marketable securities totaled approximately $156.3 million at September 28, 2013, as compared to $165.8 million at December 29, 2012. The decrease in our cash, cash equivalents and marketable securities balances was primarily due to the use of cash for operating activities in the nine months ended September 28, 2013. We believe that we will be able to satisfy our working capital requirements for the next twelve months with the liquidity provided by our existing cash, cash equivalents and marketable securities. If we are unsuccessful in increasing our revenues, improving our operating efficiency, reducing our cash outlays or increasing our available cash through financing, our cash, cash equivalents and marketable securities will further decline in fiscal 2013.

We utilize a variety of tax planning and financing strategies in an effort to manage our worldwide cash and deploy funds to locations where they are needed. As part of these strategies, we indefinitely reinvest a significant portion of our foreign earnings and our current plans do not demonstrate a need to repatriate these earnings. Should we require additional capital in the United States, we may elect to repatriate indefinitely reinvested foreign funds or raise capital in the United States through debt. If we were to repatriate indefinitely reinvested foreign funds, we would be required to accrue and pay additional United States taxes less applicable foreign tax credits.

***Days Sales Outstanding:*** Days sales outstanding from receivables, or DSO, were 55 days at September 28, 2013 compared with 49 days at December 29, 2012. Our DSO calculation is determined using the count back method and is based on gross accounts receivable (including accounts receivable for amounts in deferred revenue). The increase in DSO is primarily due to a change in customer mix resulting in a greater proportion of sales on 60 day terms.

*(In thousands)*

|  | Nine Months Ended September 28, 2013 | September 29, 2012 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(2,554) | $(15,520) |
| Net cash (used in) provided by investing activities | (11,460) | 37,281 |
| Net cash provided by financing activities | $2,129 | $2,253 |

***Cash flows from operating activities:*** Net cash used in operating activities for the nine months ended September 28, 2013 was primarily attributable to the net change in operating assets and liabilities. Our net loss of $38.9 million was offset by $43.1 million of non-cash charges consisting primarily of $21.9 million of depreciation and amortization, $9.1 million of stock-based compensation, $7.8 million of provision for excess and obsolete inventories and $2.7 million of assets written-off as part of our restructuring plan. The net change in operating assets and liabilities for the nine months ended September 28, 2013 was a use of cash of $6.7 million. The change was comprised of an increase in our accounts receivable of $18.0 million, due to an increase in sales transactions closer to our quarter end, an increase in inventory of $6.7 million as we built more inventory earlier in 2013 to support higher forecasted demand in future quarters, offset in part by an increase of $10.7 million in accounts payable driven by the timing of invoice receipt and payments to vendors, receipt of refundable taxes of $5.1 million and a decrease of prepaid expenses and other current assets of $1.9 million. Cash used included a reduction of $1.1 million in accrued liabilities.

Net cash used in operating activities for the nine months ended September 29, 2012 was primarily attributable to our net loss of $36.1 million offset in part by $24.0 million of non-cash charges consisting primarily of $9.5 million of stock-based compensation, $8.0 million of depreciation and amortization and $4.3 million of provision for excess and obsolete inventories. The net change in operating assets and liabilities for the nine months ended September 29, 2012 was a use of cash of $3.4 million comprising an increase in our accounts receivable of $4.2 million due to an increase in sales as well as the timing of transactions closer to our quarter end and an increase in inventory of $6.2 million due to a revaluation of standard costs, offset in part by an increase of $1.5 million in accounts payable driven by the timing of invoice receipts and payments to vendors. Cash was provided by an increase of $3.6 million in accrued liabilities, and partially offset by a use of cash of $1.4 million in income taxes payable.

***Cash flows from investing activities:*** Net cash used in investing activities for the nine months ended September 28, 2013 was primarily related to purchases of marketable securities totaling $69.2 million, and cash used in the acquisition of property and equipment of $7.4 million, offset by $63.5 million of proceeds from maturities of marketable securities. We carefully monitor our investments to minimize risks and have not experienced other than temporary investment losses. Our investment portfolio has not been materially impacted by the economic turmoil in the credit markets in the recent past.

Net cash provided by investing activities for the nine months ended September 29, 2012 was primarily related to $114.8 million of proceeds from maturities of marketable securities and $11.0 million from sales of marketable securities, partially offset by purchases of marketable securities totaling $82.4 million, and $6.1 million cash used in the acquisition of property and equipment.

***Cash flows from financing activities:*** Net cash provided by financing activities for the nine months ended September 28, 2013 and September 29, 2012 included $2.6 million and $2.3 million, respectively from proceeds received from the issuance of common stock and awards.

Our cash, cash equivalents and marketable securities declined in the nine months ended September 28, 2013. We continue to focus on improving our operating efficiency to increase operating cash flows. Our actions have included implementing operational expense reduction initiatives, re-timing or eliminating certain capital spending and research and development projects, focusing on timely customer collections and re-negotiating longer payment terms with our vendors. We believe that we will be able to satisfy our cash requirements for the next twelve months with the liquidity provided by our existing cash, cash equivalents and marketable securities. To the extent necessary, we may also consider establishing manufacturing and technology partnerships, or to seek short and long-term debt obligations, or to obtain new financing facilities which may not be available on terms favorable to us or at all. Our future capital requirements may vary materially from those now planned. However, if we are unsuccessful in increasing revenues, improving our operating efficiency, executing our cost reduction plan, reducing our cash outlays or increasing our available cash through financing, our cash, cash equivalents and marketable securities will decline in future fiscal quarters.

### Off-Balance Sheet Arrangements

Historically, we have not participated in transactions that have generated relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of September 28, 2013, we were not involved in any such off-balance sheet arrangements.

### Recent Accounting Pronouncements

For a discussion on the impact of recently issued accounting pronouncements, please refer to Note 2 — Recent Accounting Pronouncements and Other Reporting Considerations of the Notes to Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

### Critical Accounting Policies and Estimates

Our critical accounting policies are disclosed in our Annual Report on Form 10-K for the year ended December 29, 2012. Our critical accounting policies have not changed during the nine months ended September 28, 2013.

Furthermore, the preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our management believes that we consistently apply these judgments and estimates and the consolidated financial statements and accompanying notes fairly represent all periods presented. However, any differences between these judgments and estimates and actual results could have a material impact on our consolidated statements of income and financial position.

Critical accounting estimates, as defined by the U.S. Securities and Exchange Commission, are those that are most important to the portrayal of our consolidated financial condition and results of operations and require our management’s most difficult and subjective judgments and estimates of matters that are inherently uncertain. Our critical accounting estimates include those regarding (1) revenue recognition and the fair value of revenue elements, (2) fair value of marketable securities, (3) accruals for liabilities, including restructuring charges, (4) warranty accruals, (5) valuation of inventories, including obsolete and slow moving inventory, (6) allowance for doubtful accounts, (7) valuation of our long-lived assets as well as the assessment of recoverability of such long-lived assets, (8) provision for income taxes, tax liabilities and valuation allowance for deferred tax assets, and (9) valuation and recognition of stock-based compensation. For a discussion of our critical accounting estimates, see Item 7: “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 29, 2012.

## Market risk

As filed, 371 characters.

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A: “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report on Form 10-K for the fiscal year ended December 29, 2012. Our exposure to market risk has not changed materially since December 29, 2012.

## Controls and procedures

As filed, 3,049 characters.

### Evaluation of Disclosure Controls and Procedures

Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

### Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

### Limitations on the Effectiveness of Controls

Control systems, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control systems’ objectives are being met. Further, the design of any control systems must reflect the fact that there are resource constraints, and the benefits of all controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Control systems can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

### CEO and CFO Certifications

We have attached as exhibits to this Quarterly Report on Form 10-Q the certifications of our Chief Executive Officer and Chief Financial Officer, which are required in accordance with the Exchange Act. We recommend that this Item 4 be read in conjunction with the certifications for a more complete understanding of the subject matter presented.

## Risk factors

As filed, 882 characters.

There have been no material changes during the nine months ended September 28, 2013 to the risk factors discussed in our Annual Report on Form 10-K for the year ended December 29, 2012. If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described in our Annual Report on

Form 10-K for the year ended December 29, 2012 are not the only ones we face. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations. We may make acquisitions and investments, which could put a strain on our resources, cause ownership dilution to our stockholders and adversely affect our financial results.

Filed Nov 1, 2013.
Source: SEC EDGAR, the filing index for accession 0001039399-13-000015. Last ingested by Listed: Nov 13, 2026, 15:19 ET. No prices; not investment advice.
